Skip to main content
. 2024 Nov 23;24:389. doi: 10.1186/s12935-024-03569-x

Fig. 7.

Fig. 7

PTM combined with PTM-stimulated DCs decreases tumor size and increases immune responses. (a) The treatment schedule for a mouse tumor model injected with Lewis lung cancer (LLC) cells (n = 4 per group). Unstimulated DCs or 6.25% stimulated DCs were injected intraperitoneally at 3-d intervals after LLC tumor formation. (b) Tumor growth curves. Each line indicates tumor growth in an individual mouse. n = 2. (c) On day 18, photographs of isolated tumors in the six groups were taken. (d) Mouse survival throughout the predetermined study period of 40 d was assessed, and the survival curves were plotted using the Log-rank with Mantel-Cox test (6 mice per group); *p = 0.0453. n = 2

HHS Vulnerability Disclosure